Search Results

You are looking at 1 - 10 of 16 items for :

  • "specialty pharmacy" x
Clear All
Full access

Rowena N. Schwartz, Kirby J. Eng, Deborah A. Frieze, Tracy K. Gosselin, Niesha Griffith, Amy Hatfield Seung, Jennifer M. Hinkel, Philip E. Johnson, Shirley A. Johnson, Edward C. Li, Audrea Hotsko Szabatura and Michael K. Wong

The use of specialty pharmacy is expanding in oncology pharmacy practice. 1 Specialty pharmacies provide one channel for distribution of drugs and biologics that, from the payor perspective, creates economies of scale and streamlines delivery of

Full access

8 8 Suppl_4 Suppl_4 NCCN Task Force Report: Specialty Pharmacy Schwartz Rowena N. PharmD, BCOP Eng Kirby J. RPh Frieze Deborah A. PharmD, BCOP Gosselin Tracy K. RN, MSN, AOCN Griffith Niesha MS, RPh, FASHP Seung Amy Hatfield PharmD, BCOP Hinkel

Full access

Stacey W. MucCullough, David Blaisdell, Jonathan K. Kish, Pat Farmer, JaLyna Laney, Tom Valuck, Natalie Dickson, Johnetta Blakely, Dianna Shipley, Jesus Berdeja, Gregg Shepard, Bertrand M. Anz III, Carolyn Kelsey, Jack Taylor, Chadi Nabhan, Jeffrey F. Patton and Annette Powers

many community practices integrate specialty pharmacy (SP) services into their practice, patient education, treatment adherence, and visit scheduling coordination are becoming increasingly complex, particularly for treatments with Risk Evaluation and

Full access

Megan Gershon, Justine Pena, Chamnjot Bains, Sarah Salas, Tresa McGranahan and Seema Nagpal

-site specialty pharmacy was added as another safety measure in OC management. Conclusions: This project used published studies and multi-institutional process mapping and hazard analysis to implement a standardized ordering of TMZ for patients with brain tumors

Full access

Nikhil Khandelwal, Ian Duncan, Tamim Ahmed, Elan Rubinstein and Cheryl Pegus

cohort completed the 5-year course of tamoxifen treatment. A recent survey of managed care organizations showed that approximately 45% of oral chemotherapy is dispensed through retail pharmacy channels, 31% through specialty pharmacies, 16% through mail

Full access

Jane M. Quigley

. Understanding and incorporating hospital-based treatments, radiation therapy, and oral and intravenous oncologic use, including specialty pharmacy distribution, is a challenge. Proper integration of this information to accurately measure patient incidence

Full access

Murali Sundaram, Kathleen L. Deering, Dolly Sharma, Qing Harshaw, Jeremiah Trudeau and Jacqueline C. Barrientos

=38) from a US panel. The study generated references for HRQOL and treatment satisfaction in real-world CLL patients not on IBR. This study (IBR CLL) includes CLL patients treated with IBR for ≥6 months in health system specialty pharmacies

Full access

Saul N. Weingart, Elizabeth Brown, Peter B. Bach, Kirby Eng, Shirley A. Johnson, Timothy M. Kuzel, Terry S. Langbaum, R. Donald Leedy, Raymond J. Muller, Lee N. Newcomer, Susan O’Brien, Denise Reinke, Mark Rubino, Leonard Saltz and Ronald S. Walters

pharmacist consults with the physician. Specialty pharmacies (discussed further in a later section) may provide an additional level of safety checks, but the number of pills that a patient may receive with 1 prescription is still an issue. Capecitabine is one

Full access

Siu-Fun Wong, Mark Bounthavong, Cham P. Nguyen and Timothy Chen

education to optimize patient care. Currently, oral chemotherapy management clinics in the United States are multiplying. Most patients receive oral chemotherapy from mail order specialty pharmacies accompanied by lengthy, nonpersonalized written drug

Full access

Elizabeth Danielson, Jessica DeMartino and Jill A. Mullen

UnitedHealthcare claims data. Aggregate data are also reported. Chemotherapy, Pharmacy Benefits, Pharmacy Benefit Management Companies, and Specialty Pharmacy Programs Advances in technology resulting in complex and expensive biologics and targeted therapies have